In late March 2026, Novavax appointed Dr. Robert Walker as Executive Vice President and Head of R&D, while activist investor Shah Capital renewed its campaign to overhaul the company’s board, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results